A detailed history of Lgt Group Foundation transactions in Pfizer Inc stock. As of the latest transaction made, Lgt Group Foundation holds 742,875 shares of PFE stock, worth $20.4 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
742,875
Previous 724,601 2.52%
Holding current value
$20.4 Million
Previous $20.1 Million 3.37%
% of portfolio
0.32%
Previous 0.47%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$25.26 - $29.6 $461,601 - $540,910
18,274 Added 2.52%
742,875 $20.8 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $1.05 Million - $1.21 Million
40,655 Added 5.94%
724,601 $20.1 Million
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $1.26 Million - $1.64 Million
-48,375 Reduced 6.61%
683,946 $19.7 Million
Q3 2023

Nov 06, 2023

SELL
$32.09 - $37.51 $1.04 Million - $1.22 Million
-32,502 Reduced 4.25%
732,321 $24.3 Million
Q2 2023

Jul 27, 2023

BUY
$36.12 - $41.79 $513,084 - $593,626
14,205 Added 1.89%
764,823 $28.1 Million
Q1 2023

Apr 20, 2023

BUY
$39.39 - $51.28 $240,279 - $312,808
6,100 Added 0.82%
750,618 $30.6 Million
Q4 2022

Feb 09, 2023

BUY
$41.75 - $54.5 $8.56 Million - $11.2 Million
204,971 Added 37.99%
744,518 $38.2 Million
Q3 2022

Oct 19, 2022

SELL
$43.76 - $53.42 $8.12 Million - $9.91 Million
-185,497 Reduced 25.58%
539,547 $23.6 Million
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $6.34 Million - $7.52 Million
136,280 Added 23.15%
725,044 $38 Million
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $7.64 Million - $9.47 Million
166,991 Added 39.59%
588,764 $30.4 Million
Q4 2021

May 03, 2022

BUY
$41.32 - $61.25 $17.4 Million - $25.8 Million
421,773 New
421,773 $24.9 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lgt Group Foundation Portfolio

Follow Lgt Group Foundation and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Group Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Group Foundation with notifications on news.